The Lupus Foundation of America describes lupus as a chronic disease that attacks the immune system, the part of the body ...

Cabaletta has been evaluating the CAR-T, called resecabtagene autoleucel or rese-cel , across six so-called RESET studies ...

Kris Aquino revealed her “pain and struggle” amid suffering from lupus flare fever for over two weeks now, appealing to the ...

Pericarditis recurrence in lupus is more likely — and has a dose-dependent relationship — with oral prednisone treatment, ...

Patients with cutaneous lupus erythematosus who used hydroxychloroquine had a significantly reduced risk of developing systemic lupus erythematosus.

Cartesian Therapeutics is a clinical-stage company pioneering mRNA cell therapies for the treatment of autoimmune diseases. The Company’s lead asset, Descartes-08, is an mRNA CAR-T entering Phase 3 ...

After a previously reported positive phase 2 trial in systemic lupus erythematosus (SLE), the TYK2 inhibitor deucravacitinib ...

More than one-third of patients with systemic lupus erythematosus experience a flare after starting dialysis for end-stage ...

African Americans, particularly women, and residents of Southern states face disproportionately high rates of SLE-related mortality.

A Jordanian study finds that over one-third of women with lupus suffer from depression, and nearly one-third have ...

Nkarta is laying off a third of its employees, including half of the biotech’s executive leadership, as the company diverts ...